UTI-Medium Duration Fund - Direct (G) - Mutual Fund Analysis | Complete Fund Review with Performance, Portfolio, and Risk Analysis
Comprehensive analysis of UTI-Medium Duration Fund - Direct (G) (30274) providing detailed insights into fund performance, portfolio holdings, risk metrics, expense ratios, and investment recommendations.
UTI-Medium Duration Fund - Direct (G)
UTI Asset Management Company Ltd
The investment objective of the scheme is to generate reasonable income by investing in debt & money market securities such that the Macaulay duration of the portfolio is between 3 to 4 years. However there can be no assurance that the investment objective of the Scheme will be achieved. The Scheme does not guarantee / indicate any returns.
Fund Health Radar
A comprehensive at-a-glance view of key mutual fund health indicatorsHover or click any card to view detailed metrics
Performance
Moderate Returns
Risk
Moderate Risk
Expenses
Low Expense Ratio
Portfolio Mix
Debt Focused
Management
Experienced Team
Quality Score
Average Quality
UTI-Medium Duration Fund - Direct (G) - NAV History (1Y)
Showing 1Y NAV history
Performance across different time periods
Neutral Entry Point
Fund shows mixed signals. Consider your investment timeline and risk tolerance.
Review detailed analysis and consider dollar-cost averaging through SIPs.
Neutral Entry Point
Fund shows mixed signals. Consider your investment timeline and risk tolerance.
Review detailed analysis and consider dollar-cost averaging through SIPs.
Key Factors Analysis
Alpha Generation
Outperformance vs benchmark
Management Stability
Fund manager experience
1-Year Returns
Recent performance momentum
Cost Efficiency
Fund management costs
Risk Assessment
Risk-adjusted returns
Long-term Track Record
Historical performance consistency
Equity Exposure
Market exposure level
Fund Size
Assets under management
Investment Timing Insights
See how your money can grow and compare with popular investment options
Your Investment
Compare With Popular Options
Disclaimer: Returns are illustrative and based on assumed rates. Mutual fund investments are subject to market risk. Please read scheme documents carefully.
Risk Metrics (3 Years)
Risk Level
| Company | Industry | % Assets |
|---|---|---|
| GSEC2033 | Govt. Securities | 16.68% |
| Net CA & Others | Debt Others | 13.82% |
| GSEC2032 | Govt. Securities | 10.34% |
| Uttar Pradesh 2033 | Govt. Securities | 7.90% |
| GSEC2032 | Govt. Securities | 7.47% |
| Bajaj Finance Ltd | Finance - Large | 7.40% |
| GSEC2034 | Govt. Securities | 6.39% |
| ERIS Lifesciences Ltd | Pharmaceuticals - Indian - Formulations | 4.99% |
| Aditya Birla Real Estate Ltd | Construction - Factories / Offices / Commercial | 4.93% |
| Tata Motors Passenger Vehicles Ltd | Automobiles - LCVs/HCVs | 4.91% |
Compare against Medium Duration Fund category average
Performance Summary
This comparison shows how the fund performs relative to the Medium Duration Fund category average. Positive values indicate outperformance, while negative values show underperformance.
Compare with similar funds in Medium Duration Fund category
UTI-Medium Duration Fund - Direct (G) vs Category Average
Similar Funds Comparison
| Fund Name | NAV | 6M | 1Y | 3Y |
|---|---|---|---|---|
| Invesco India Medium Duration Fund-Dir(G) | ₹1303.35 | 4.38% | 8.08% | 7.56% |
| Invesco India Medium Duration Fund-Dir(IDCW-Discr) | ₹1303.27 | 4.38% | 8.07% | 7.56% |
| Invesco India Medium Duration Fund-Reg(IDCW-Discr) | ₹1257.86 | 3.98% | 7.32% | 6.71% |
| Invesco India Medium Duration Fund-Reg(G) | ₹1257.85 | 3.97% | 7.32% | 6.71% |
| Invesco India Medium Duration Fund-Dir(IDCW-Q) | ₹1049.58 | 4.38% | 8.07% | 7.55% |
| Invesco India Medium Duration Fund-Reg(IDCW-Q) | ₹1048.32 | 3.97% | 7.31% | 6.75% |
| DSP Bond Fund - Direct (G) | ₹88.68 | 4.86% | 8.63% | 7.76% |
| DSP Bond Fund - Regular (G) | ₹83.44 | 4.67% | 8.25% | 7.38% |
| Sundaram Medium Duration Fund - Direct (G) | ₹78.23 | 3.64% | 6.92% | 6.50% |
| Sundaram Medium Duration Fund - (G) | ₹69.90 | 3.21% | 6.03% | 5.58% |
Category Average Returns
Sunil Patil
A seasoned investment professional with over 11 years of experience in equity research and fund management. Known for consistent performance and a disciplined investment approach focused on quality growth stocks.